Yıl: 2023 Cilt: 28 Sayı: 3 Sayfa Aralığı: 259 - 265 Metin Dili: İngilizce DOI: 10.21673/anadoluklin.1288549 İndeks Tarihi: 05-10-2023

The effect of nebulized magnesium sulfate on asthma attacks in the children

Öz:
Aim: This study aimed to determine the effect of adding nebulized magnesium sulfate to standard treatment in children with moderate to severe acute asthma attacks. Methods: Pediatric patients admitted to the emergency department with moderate to severe asthma attacks were included in the study. The patients were divided into two groups. Group S received standard treatment, while Group M received nebulized magnesium sulfate in addition to standard therapy. Results: A total of 129 patients were included in the study, 86 (66.7%) were male, and the median (minimum-maximum) age was 4 (2-8) years. When groups were compared, oxygen saturation at hour 1 was higher (p=0.024), and the PRAM (preschool respiratory assessment measure) scores at the 4th hour were lower (p=0.008) in the group that received magnesium sulfate. The groups had no differences regarding any of the other parameters at the 1st and 4th hours (p>0.05). Conclusion: Adding nebulized magnesium sulfate to standard treatment in children with asthma attacks improves oxygen saturation faster and positively affects PRAM score at hour 4.
Anahtar Kelime: Adrenergic beta-2 agonists asthma asthmatic crisis child inhalers magnesium sulfate

Nebulize magnezyum sülfatın çocuklarda astım atakları üzerine etkisi

Öz:
Amaç: Bu çalışmanın amacı orta ila şiddetli akut astım atakları olan çocuklarda standart tedaviye nebülize magnezyum sülfat eklenmesinin etkisini belirlemektir. Yöntem: Acil servise orta ve şiddetli astım atağı ile başvuran pediatrik hastalar çalışmaya dâhil edildi. Hastalar iki gruba ayrıldı. Grup S standart tedavi alırken, Grup M standart tedaviye ek olarak nebulize magnezyum sülfat aldı. Bulgular: Çalışmaya toplam 129 hasta dâhil edildi, 86’sı (%66,7) erkekti ve ortanca yaş (minimum-maksimum) 4(2-8) idi. Gruplar karşılaştırıldığında magnezyum sülfat verilen grupta 1. saat oksijen satürasyonu daha yüksek (p=0,024), 4. saat PRAM skoru (PRAM: Okul öncesi solunum değerlendirme ölçüsü) daha düşüktü (p=0,008). Diğer parametrelerde gruplar arasında 1. ve 4. saatte fark yoktu (p>0,05). Sonuç: Astım atağı olan çocuklarda standart tedaviye nebülize magnezyum sülfat eklenmesi oksijen satürasyonunu daha hızlı iyileştirmekte ve 4. saatteki PRAM skorunu olumlu yönde etkilemektedir.
Anahtar Kelime: Adrenerjk beta-2 agonistler astım astım krizi çocuk inhalerler magnezyum sülfat

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Daengsuwan T, Watanatham S. A comparative pilot study of the efficacy and safety of nebulized magnesium sulfate and intravenous magnesium sulfate in children with severe acute asthma. Asian Pac J Allergy Immunol. 2017;35(2):108-12.
  • 2. Mohammed S, Goodacre S. Intravenous and nebulised magnesium sulphate for acute asthma: systematic review and meta-analysis. Emerg Med J. 2007;24(12):823-30.
  • 3. Knightly R, Milan SJ, Hughes R, et al. Inhaled magne- sium sulfate in the treatment of acute asthma. Cochrane Database Syst Rev. 2017;11(11):CD003898.
  • 4. GIF Asthma. Global strategy for asthma management and prevention. Global Initiative for Asthma; 2015. Ac- cess date: 08.10.2022. Available from: https://ginasthma. org/wp-content/uploads/2016/01/GINA_Report_2015_ Aug11-1.pdf.
  • 5. Goodacre S, Cohen J, Bradburn M, et al. Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a double- blind, randomised controlled trial. Lancet Respir Med. 2013;1(4):293-300.
  • 6. Singh AK, Gaur S, Kumar R. A randomized controlled trial of intravenous magnesium sulphate as an adjunct to standard therapy in acute severe asthma. Iran J. Allergy. Asthma Immunol. 2008;7(4):221-9.
  • 7. Kew KM, Kirtchuk L, Michell CI. Intravenous magne- sium sulfate for treating adults with acute asthma in the emergency department. Cochrane Database Syst Rev. 2014;(5):CD010909.
  • 8. Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 statement: updated guidelines for re- porting parallel group randomised trials. Int J Surg 2011;9:672–7.
  • 9. Chalut DS, Ducharme FM, Davis GM. The Preschool Re- spiratory Assessment Measure (PRAM): a responsive in- dex of acute asthma severity. J Pediatr. 2000;137(6):762- 8.
  • 10. Classen H; Jacob R; Schimatschek H. Interactions of Magnesium with Direct and Indirect Acting Sympatho- mimetic Amines. Magnesium. 1987;9:80-7.
  • 11. Middleton E Jr. Antiasthmatic drug therapy and calci- um ions: review of pathogenesis and role of calcium. J Pharm Sci. 1980;69(2):243-51.
  • 12. Hill J, Britton J. Dose-response relationship and time- course of the effect of inhaled magnesium sulphate on airflow in normal and asthmatic subjects. Br J Clin Phar- macol. 1995;40(6):539-44.
  • 13. Iseri LT, French JH. Magnesium: nature’s physiologic cal- cium blocker. Am Heart J. 1984;108(1):188-93.
  • 14. Nannini LJ Jr, Pendino JC, Corna RA, Mannarino S, Quispe R. Magnesium sulfate as a vehicle for nebulized salbutamol in acute asthma. Am J Med. 2000;108(3):193- 7.
  • 15. Mahajan P, Haritos D, Rosenberg N, Thomas R. Com- parison of nebulized magnesium sulfate plus albuterol to nebulized albuterol plus saline in children with acute exacerbations of mild to moderate asthma. J Emerg Med. 2004;27(1):21-5.
  • 16. Aggarwal P, Sharad S, Handa R, Dwiwedi SN, Irshad M. Comparison of nebulised magnesium sulphate and sal- butamol combined with salbutamol alone in the treat- ment of acute bronchial asthma: a randomised study. Emerg Med J. 2006;23(5):358-62.
  • 17. National Institutes of Health. Global strategy for asthma management and prevention [updated 2005]. Access date: 25.10. 2022. Available from: www.ginasthma.org.
  • 18. Ducharme FM, Davis GM. Measurement of respira- tory resistance in the emergency department: feasi- bility in young children with acute asthma. Chest. 1997;111(6):1519-25.
  • 19. Gorelick MH, Stevens MW, Schultz TR, Scribano PV. Performance of a novel clinical score, the Pediatric Asthma Severity Score (PASS), in the evaluation of acute asthma. Acad Emerg Med. 2004;11(1):10-8.
  • 20. Canny GJ, Reisman J, Healy R, et al. Acute asthma: ob- servations regarding the management of a pediatric emergency room. Pediatrics. 1989;83(4):507-12.
  • 21. Birken CS, Parkin PC, Macarthur C. Asthma sever- ity scores for preschoolers displayed weaknesses in re- liability, validity, and responsiveness. J Clin Epidemiol. 2004;57(11):1177-81.
APA aslan m, KARABAĞ H, topal e, Gozukara Bag H, kaplan f (2023). The effect of nebulized magnesium sulfate on asthma attacks in the children. , 259 - 265. 10.21673/anadoluklin.1288549
Chicago aslan mehmet,KARABAĞ HİLAL,topal erdem,Gozukara Bag Harika Gozde,kaplan fatih The effect of nebulized magnesium sulfate on asthma attacks in the children. (2023): 259 - 265. 10.21673/anadoluklin.1288549
MLA aslan mehmet,KARABAĞ HİLAL,topal erdem,Gozukara Bag Harika Gozde,kaplan fatih The effect of nebulized magnesium sulfate on asthma attacks in the children. , 2023, ss.259 - 265. 10.21673/anadoluklin.1288549
AMA aslan m,KARABAĞ H,topal e,Gozukara Bag H,kaplan f The effect of nebulized magnesium sulfate on asthma attacks in the children. . 2023; 259 - 265. 10.21673/anadoluklin.1288549
Vancouver aslan m,KARABAĞ H,topal e,Gozukara Bag H,kaplan f The effect of nebulized magnesium sulfate on asthma attacks in the children. . 2023; 259 - 265. 10.21673/anadoluklin.1288549
IEEE aslan m,KARABAĞ H,topal e,Gozukara Bag H,kaplan f "The effect of nebulized magnesium sulfate on asthma attacks in the children." , ss.259 - 265, 2023. 10.21673/anadoluklin.1288549
ISNAD aslan, mehmet vd. "The effect of nebulized magnesium sulfate on asthma attacks in the children". (2023), 259-265. https://doi.org/10.21673/anadoluklin.1288549
APA aslan m, KARABAĞ H, topal e, Gozukara Bag H, kaplan f (2023). The effect of nebulized magnesium sulfate on asthma attacks in the children. ANADOLU KLİNİĞİ TIP BİLİMLERİ DERGİSİ, 28(3), 259 - 265. 10.21673/anadoluklin.1288549
Chicago aslan mehmet,KARABAĞ HİLAL,topal erdem,Gozukara Bag Harika Gozde,kaplan fatih The effect of nebulized magnesium sulfate on asthma attacks in the children. ANADOLU KLİNİĞİ TIP BİLİMLERİ DERGİSİ 28, no.3 (2023): 259 - 265. 10.21673/anadoluklin.1288549
MLA aslan mehmet,KARABAĞ HİLAL,topal erdem,Gozukara Bag Harika Gozde,kaplan fatih The effect of nebulized magnesium sulfate on asthma attacks in the children. ANADOLU KLİNİĞİ TIP BİLİMLERİ DERGİSİ, vol.28, no.3, 2023, ss.259 - 265. 10.21673/anadoluklin.1288549
AMA aslan m,KARABAĞ H,topal e,Gozukara Bag H,kaplan f The effect of nebulized magnesium sulfate on asthma attacks in the children. ANADOLU KLİNİĞİ TIP BİLİMLERİ DERGİSİ. 2023; 28(3): 259 - 265. 10.21673/anadoluklin.1288549
Vancouver aslan m,KARABAĞ H,topal e,Gozukara Bag H,kaplan f The effect of nebulized magnesium sulfate on asthma attacks in the children. ANADOLU KLİNİĞİ TIP BİLİMLERİ DERGİSİ. 2023; 28(3): 259 - 265. 10.21673/anadoluklin.1288549
IEEE aslan m,KARABAĞ H,topal e,Gozukara Bag H,kaplan f "The effect of nebulized magnesium sulfate on asthma attacks in the children." ANADOLU KLİNİĞİ TIP BİLİMLERİ DERGİSİ, 28, ss.259 - 265, 2023. 10.21673/anadoluklin.1288549
ISNAD aslan, mehmet vd. "The effect of nebulized magnesium sulfate on asthma attacks in the children". ANADOLU KLİNİĞİ TIP BİLİMLERİ DERGİSİ 28/3 (2023), 259-265. https://doi.org/10.21673/anadoluklin.1288549